...
首页> 外文期刊>Frontiers in Medicine >Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China
【24h】

Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China

机译:住院治疗非酒精脂肪肝病的鲜明原因:10年的中国横断面多中心研究

获取原文
           

摘要

Background: The clinical burden and natural history of non-alcoholic fatty liver disease (NAFLD) vary globally. We aimed to investigate NAFLD-related mortality profiles in hospitalized patients in southern China. Methods: A multicenter retrospective investigation with a 10-year study period (2009–2018) analyzed 10,071 deaths during hospitalization (NAFLD: 2,015; other liver diseases: 1,140; without liver diseases: 6,916) was performed using a multiple cause of death analysis. Medical histories and biochemistry and imaging findings were extracted from the electronic medical record system. The underlying causes of death were classified by 10th Revision of the International Classification of Diseases (ICD-10) codes. Results: The distribution of death causes in patients with NAFLD has stabilized over time, with cardio- and cerebral vascular disease (CVD) ranked first (35.6%), followed by extrahepatic malignancies (22.6%), infection (11.0%), kidney disease (7.5%), liver-related diseases (5.2%), respiratory diseases (3.9%), digestive diseases (3.5%), endocrine diseases (3.5%), and other diseases (7.2%). NAFLD patients had more deaths attributable to CVD, extrahepatic malignancies, liver-related diseases (all P 0.001) and multiorgan failure than the deceased controls. The severity of steatosis was independently associated with these relationships (liver-related diseases: OR = 1.37, 95% CI: 1.20–1.59, cardio- and cerebrovascular diseases: OR = 1.23, 95% CI: 1.19–1.31, infectious diseases: OR = 1.14, 95% CI: 1.04–1.26, and renal diseases: OR = 1.21, 95% CI: 1.02–1.47, all P 0.05) after adjustment for sex, body mass index (BMI), fasting blood glucose, low-density lipoprotein cholesterol, uric acid, metabolic syndromes and fibrosis index based on the 4 factors. Conclusion : NAFLD patients had higher proportions of death due to underlying CVD and liver-related diseases than the general population in China; these proportions positively correlated with steatosis degree.
机译:背景:非酒精脂肪肝病(NAFLD)的临床负担和自然历史在全球各自各种各种差异。我们旨在调查中国南方住院患者的NAFLD相关死亡率型材。方法:使用多种死亡分析,分析了10年期研究期(2009 - 2018年)分析了10,09-2018期)分析了10,07-2018岁的死亡人数(NAFLD:2,015;其他肝脏疾病:1,140;没有肝脏疾病:6,916)。从电子医疗系统中提取了医疗历史和生物化学和成像结果。死亡的基本原因是第10次修订疾病(ICD-10)代码的国际分类。结果:NAFLD患者的死亡原因分布随着时间的推移稳定,心血管和脑血管疾病(CVD)排名第一(35.6%),其次是脱毛恶性肿瘤(22.6%),感染(11.0%),肾病(7.5%),肝脏相关疾病(5.2%),呼吸系统疾病(3.9%),消化系统疾病(3.5%),内分泌疾病(3.5%)和其他疾病(7.2%)。 NAFLD患者归因于CVD,肝外部病毒性恶性肿瘤,肝癌有关的疾病(所有P <0.001)和多功能患者的死亡。脂肪变性的严重程度与这些关系无关(肝脏有关的疾病:或= 1.37,95%CI:1.20-1.59,心血管和脑血管疾病:或= 1.23,95%CI:1.19-1.31,传染病:或= 1.14,95%CI:1.04-1.26和肾病:或= 1.21,95%CI:1.02-1.47,所有P <0.05)进行性别,体重指数(BMI),禁食血糖,低 - 基于4个因素的强度脂蛋白胆固醇,尿酸,代谢综合征和纤维化指数。结论:NAFLD患者因潜在的CVD和肝病有关的疾病而比中国的一般人群更高的死亡比例更高;这些比例与脂肪变性程度正相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号